Cargando…

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa

BACKGROUND: In South Africa, roughly half of the drug-resistant TB cases diagnosed are reported to have been started on treatment. We determined the proportion of persons diagnosed with rifampicin resistant (RR-) TB who initiated treatment in Johannesburg after the introduction of decentralized RR-T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Denise, Schnippel, Kathryn, Govathson, Caroline, Sineke, Tembeka, Black, Andrew, Long, Lawrence, Berhanu, Rebecca, Rosen, Sydney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529007/ https://www.ncbi.nlm.nih.gov/pubmed/28746344 http://dx.doi.org/10.1371/journal.pone.0181238

Ejemplares similares

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2019)

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Understanding the Reasons for Deferring ART Among Patients Diagnosed Under the Same-Day-ART Policy in Johannesburg, South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

Self-reported motivators for HIV testing in the treat-all era among HIV positive patients in Johannesburg, South Africa
por: Mokhele, Idah, et al.
Publicado: (2021)

Women’s costs for accessing comprehensive sexual and reproductive health services: findings from an observational study in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study
por: Onoya, Dorina, et al.
Publicado: (2020)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
por: Schnippel, Kathryn, et al.
Publicado: (2016)

Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa
por: Nnambalirwa, Maria, et al.
Publicado: (2016)

Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
por: d'Elia, Alexander, et al.
Publicado: (2015)

Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2020)

Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis
por: Schnippel, Kathryn, et al.
Publicado: (2015)

“I was scared dating… who would take me with my status?”—Living with HIV in the era of UTT and U = U: A qualitative study in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2023)

HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

The right combination – treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2017)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Pneumonic Plague in Johannesburg, South Africa, 1904
por: Evans, Charles M., et al.
Publicado: (2018)

Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

Attrition in HIV care following HIV diagnosis: a comparison of the pre‐UTT and UTT eras in South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
por: Larson, Bruce, et al.
Publicado: (2012)

Environmental Silica Dust Exposure and Pulmonary Tuberculosis in Johannesburg, South Africa
por: Kootbodien, Tahira, et al.
Publicado: (2019)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2018)

Perceived efficacy of HIV treatment-as-prevention among university students in Johannesburg, South Africa
por: Bor, Jacob, et al.
Publicado: (2021)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa
por: Musakwa, Nozipho Orykah, et al.
Publicado: (2021)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
por: Benade, Mariet, et al.
Publicado: (2022)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2016)

Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa
por: Rosen, Sydney, et al.
Publicado: (2010)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa
por: van Hougenhouck-Tulleken, Wesley G., et al.
Publicado: (2014)

Sarcoidosis in Johannesburg, South Africa: A retrospective study
por: Morar, R, et al.
Publicado: (2022)

Psychosexual experiences of men following radiotherapy for prostate cancer in Johannesburg, South Africa
por: Phahlamohlaka, Matheko N., et al.
Publicado: (2018)

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2013)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pec4ak8kffim666rtvii096su0